BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30642547)

  • 1. Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.
    Thompson JC; Fan R; Black T; Yu GH; Savitch SL; Chien A; Yee SS; Sen M; Hwang WT; Katz SI; Feldman M; Vachani A; Carpenter EL
    Lung Cancer; 2019 Jan; 127():25-33. PubMed ID: 30642547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples.
    Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G
    BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
    Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
    J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
    Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer.
    Shibaki R; Murakami S; Shinno Y; Matsumoto Y; Goto Y; Kanda S; Horinouchi H; Fujiwara Y; Motoi N; Yamamoto N; Ohe Y
    Thorac Cancer; 2019 Apr; 10(4):815-822. PubMed ID: 30762312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic Natural Killer Subpopulations as a Prognostic Factor of Malignant Pleural Effusion.
    Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
    Lung; 2019 Feb; 197(1):53-60. PubMed ID: 30523401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non-small-cell lung cancer.
    Zhang X; Wang X; Wen Y; Chen S; Zhou C; Wu F
    Clin Transl Med; 2024 Apr; 14(4):e1649. PubMed ID: 38629624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant pleural effusion cell blocks are substitutes for tissue in EML4-ALK rearrangement detection in patients with advanced non-small-cell lung cancer.
    Zhong J; Li X; Bai H; Zhao J; Wang Z; Duan J; An T; Wu M; Wang Y; Wang S; Wang J
    Cytopathology; 2016 Dec; 27(6):433-443. PubMed ID: 27060609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
    Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
    Shojaee S; Singh I; Solsky I; Nana-Sinkam P
    Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
    Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
    Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer.
    Wang J; Ling L; Chen S; Chou L; Wang Y; Hu L
    Lab Med; 2024 May; 55(3):271-276. PubMed ID: 37566516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
    Zhang F; Wang J; Fu J; Hu L; Zheng X; Wang Y; Chen B
    J Clin Lab Anal; 2020 Mar; 34(3):e23091. PubMed ID: 31709646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions.
    Schwed Lustgarten DE; Thompson J; Yu G; Vachani A; Vaidya B; Rao C; Connelly M; Udine M; Tan KS; Heitjan DF; Albelda S
    Ann Am Thorac Soc; 2013 Dec; 10(6):582-9. PubMed ID: 24236662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
    Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
    Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.
    Zhang F; Wang J; Zheng X; Hu L; Chen J; Jiang F; Wang Y
    J Clin Lab Anal; 2018 Oct; 32(8):e22576. PubMed ID: 29797475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer.
    Zhou J; Yao H; Zhao J; Zhang S; You Q; Sun K; Zou Y; Zhou C; Zhou J
    Histopathology; 2015 Jun; 66(7):949-54. PubMed ID: 25257756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion.
    Yang J; Zhu Y; Wu L; Zhu W; Zhang X; Yang Y; Xu C
    Clin Respir J; 2018 Jan; 12(1):279-284. PubMed ID: 27402224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.